Chronic social defeat stress model: Behavioral features, antidepressant action, and interaction with biological risk factors

Psychopharmacology

Volumn 224, Issue 2, 2012, Pages 313-325

  Venzala, E ^a   Garcia Garcia A L ^a,b   Elizalde, N ^a   Delagrange, P ^c   Tordera, R M ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Antidepressant; Anxiety; Chronic social defeat stress; Depression; Social interaction; VGLUT1

Indexed keywords

FLUOXETINE; MESSENGER RNA; SODIUM CHLORIDE; TIANEPTINE; VENLAFAXINE; VESICULAR GLUTAMATE TRANSPORTER 1;

AMYGDALOID NUCLEUS; ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ANXIETY; ARTICLE; CHRONIC SOCIAL DEFEAT STRESS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME REGULATION; FREEZING; HETEROZYGOSITY; MALE; MEMORY; MOTOR ACTIVITY; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; SOCIAL AVOIDANCE BEHAVIOR; SOCIAL INTERACTION; SOCIAL STRESS; TREATMENT DURATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CYCLOHEXANOLS; DEPRESSION; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FLUOXETINE; MALE; MICE; MICE, INBRED C57BL; RISK FACTORS; RNA, MESSENGER; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL; THIAZEPINES; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

EID: 84868195322     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2754-5     Document Type: Article

References (68)

1. Ago Y, Takahashi K, Nakamura S, Hashimoto H, Baba A, Matsuda T (2007) Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test. J Pharmacol Sci 104:153-8 (Pubitemid 46974989)
2. Aleksandrovskǐ IuA, Avedisova AS, Boev IV, Bukhanovkskǐ AO, Voloshin VM, Tsygankov BD, Shamreǐ BK (2005) Efficacy and tolerability of coaxil (tianeptine) in the therapy of posttraumatic stress disorder. Zh Nevrol Psikhiatr Im S S Korsakova 105:24-9
3. Balschun D, Moechars D, Callaerts-Vegh Z, Vermaercke B, Van Acker N, Andries L, D'Hooge R (2010) Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning. Cereb Cortex 20:684-93
4. Berrocoso E, Rojas-Corrales MO, Micó JA (2004) Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice. Neurosci Lett 363:25-8 (Pubitemid 38639845)
5. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864-8 (Pubitemid 43228853)
6. Besançon G, Servillat T, Albert E (1993) Drugs for stress. Encephale 19(Spec No 1):203-7
7. Bjorkqvist K (2001) Social defeat as a stressor in humans. Physiol Behav 73:435-42 (Pubitemid 32595719)
8. Brion S, Audrain S, de Bodinat C (1996) Major depressive episodes in patients over 70 years of age. Evaluation of the efficiency and acceptability of tianeptine and mianserin. Presse Med 25:461-8 (Pubitemid 26109372)
9. Covington HE 3rd, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM, Renthal W, Rush AJ 3rd, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C, Haggarty SJ, Nestler EJ (2009) Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29:11451-60
10. Davidson JR, DuPont RL, Hedges D, Haskins JT (1999) Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry 60:528-35 (Pubitemid 29413473)
11. Denmark A, Tien D, Wong K, Chung A, Cachat J, Goodspeed J, Grimes C, Elegante M, Suciu C, Elkhayat S, Bartels B, Jackson A, Rosenberg M, Chung KM, Badani H, Kadri F, Roy S, Tan J, Gaikwad S, Stewart A, Zapolsky I, Gilder T, Kalueff AV (2010) The effects of chronic social defeat stress on mouse self-grooming behavior and its patterning. Behav Brain Res 208:553-9
12. Dulawa SC, Hen R (2005) Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 29:771-83 (Pubitemid 40762599)
13. Elizalde N, Gil-Bea FJ, Ramirez MJ, Aisa B, Lasheras B, Del Rio J, Tordera RM (2008) Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment. Psychopharmacology 199:1-14
14. Elizalde N, Pastor PM, Garcia-García AL, Serres F, Venzala E, Huarte J, Ramírez MJ, Del Rio J, Sharp T, Tordera RM (2010) Regulation of markers of synaptic function in mouse models of depression: chronic mild stress and decreased expression of VGLUT1. J Neurochem 114:1302-14
15. Fegley DB, Holmes A, Riordan T, Faber CA, Weiss JR, Ma S, Batkai S, Pacher P, Dobolyi A, Murphy A, Sleeman MW, Usdin TB (2008) Increased fear- and stress-related anxiety-like behavior in mice lacking tuberoinfundibular peptide of 39 residues. Genes Brain Behav 7:933-42
16. Friedlander AH, Friedlander IK, Marder SR (2004) Posttraumatic stress disorder: psychopathology, medical management, and dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:5-11 (Pubitemid 38064258)
17. Froger N, Palazzo E, Boni C, Hanoun N, Saurini F, Joubert C, Dutriez-Casteloot I, Enache M, Maccari S, Barden N, Cohen-Salmon C, Hamon M, Lanfumey L (2004) Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. J Neurosci 24:2787-96 (Pubitemid 38380956)
18. Garcia-Garcia AL, Elizalde N, Matrov D, Harro J, Wojcik SM, Venzala E, Ramírez MJ, Del Rio J, Tordera RM (2009) Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biol Psychiatry 66:275-82
19. Goodnick PJ, Goldstein BJ (1998) Selective serotonin reuptake inhibitors in affective disorders - II. Efficacy and quality of life. J Psychopharmacol 12:S21-54 (Pubitemid 28556669)
20. Gupta RK (2009) Major depression: an illness with objective physical signs. World J Biol Psychiatry 10:196-201
21. Hammen C (2005) Stress and depression. Annu Rev Clin Psychol 1:293-319 (Pubitemid 43843953)
22. Hicks BM, DiRago AC, Iacono WG, McGue M (2009) Gene-environment interplay in internalizing disorders: consistent findings across six environmental risk factors. J Child Psychol Psychiatry 50:1309-17
23. Kawasaki T, Ago Y, Yano K, Araki R, Washida Y, Onoe H, Chaki S, Nakazato A, Hashimoto H, Baba A, Takuma K, Matsuda T (2011) Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice. Neuropharmacology 60:397-404
24. Kendler KS, Karkowski LM, Prescott CA (1998) Stressful life events and major depression: risk period, long-term contextual threat, and diagnostic specificity. J Nerv Ment Dis 186:661-9 (Pubitemid 29103863)
25. Kendler KS, Karkowski LM, Prescott CA (1999) The assessment of dependence in the study of stressful life events: validation using a twin design. Psychol Med 29:1455-60
26. Kendler KS, Thornton LM, Gardner CO (2001) Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry 158:582-6 (Pubitemid 32289820)
27. Kessler RC (1997) The effects of stressful life events on depression. Annu Rev Psychol 48:191-214 (Pubitemid 127485175)
28. Kessler H, Roth J, von Wietersheim J, Deighton RM, Traue HC (2007) Emotion recognition patterns in patients with panic disorder. Depress Anxiety 24:223-6 (Pubitemid 46789716)
29. Koolhaas JM, De Boer SF, De Rutter AJ, Meerlo P, Sgoifo A (1997) Social stress in rats and mice. Acta Physiol Scand Suppl 640:69-72 (Pubitemid 27496284)
30. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, Laplant Q, Graham A, Lutter M, Lagace DC, Ghose S, Reister R, Tannous P, Green TA, Neve RL, Chakravarty S, Kumar A, Eisch AJ, Self DW, Lee FS, Tamminga CA, Cooper DC, Gershenfeld HK, Nestler EJ (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131:391-404 (Pubitemid 47576141)
31. Krishnan V, Berton O, Nestler E (2008) The use of animal models in psychiatric research and treatment. Am J Psychiatry 165:1109
32. Kulkarni SK, Dhir A (2007) Effect of various classes of antidepressants in behavioral paradigms of despair. Prog Neuropsychopharmacol Biol Psychiatry 31:1248-54 (Pubitemid 47081311)
33. Lagace DC, Donovan MH, DeCarolis NA, Farnbauch LA, Malhotra S, Berton O, Nestler EJ, Krishnan V, Eisch AJ (2010) Adult hippocampal neurogenesis is functionally important for stress-induced social avoidance. Proc Natl Acad Sci USA 107:4436-41
34. Lagerspetz K, Tirri R (1961) The induction of physiological tolerance to promazine in mice. Ann Med Exp Biol Fenn Suppl 5:1-24
35. Lucki I, Dalvi A, Mayorga AJ (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 155:315-22 (Pubitemid 32477289)
36. Lutter M, Sakata I, Osborne-Lawrence S, Rovinsky SA, Anderson JG, Jung S, Birnbaum S, Yanagisawa M, Elmquist JK, Nestler EJ, Zigman JM (2008) The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 11:752-3 (Pubitemid 351896679)
37. Mazure CM, Bruce ML, Maciejewski PK, Jacobs SC (2000) Adverse life events and cognitive-personality characteristics in the prediction of major depression and antidepressant response. Am J Psychiatry 157:896-903 (Pubitemid 30412339)
38. McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E (2010) The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry 15:237-49
39. Miczek KA, Yap JJ, Covington HE 3rd (2008) Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake. Pharmacol Ther 120:102-28
40. Molteni R, Calabrese F, Maj PF, Olivier JD, Racagni G, Ellenbroek BA, Riva MA (2009) Altered expression and modulation of activity-regulated cytoskeletal associated protein (Arc) in serotonin transporter knockout rats. Eur Neuropsychopharmacol 19:898-904
41. Monroe SM, Torres LD, Guillaumot J, Harkness KL, Roberts JE, Frank E, Kupfer D (2006) Life stress and the long-term treatment course of recurrent depression: III. Nonsevere life events predict recurrence for medicated patients over 3 years. J Consult Clin Psychol 74:112-20
42. Nierenberg AA (2001) Do some antidepressants work faster than others? J Clin Psychiatry 62:22-5 (Pubitemid 32601345)
43. Onder E, Tural U, Aker T (2006) A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatr 21:174-9
44. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327-36 (Pubitemid 8225714)
45. Reznikov LR, Grillo CA, Piroli GG, Pasumarthi RK, Reagan LP, Fadel J (2007) Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment. Eur J Neurosci 25:3109-14 (Pubitemid 46888811)
46. Rickels K, Pollack MH, Sheehan DV, Haskins JT (2000) Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry 157:968-74 (Pubitemid 30412349)
47. Robert G, Drapier D, Bentué-Ferrer D, Renault A, Reymann JM (2011) Acute and chronic anxiogenic-like response to fluoxetine in rats in the elevated plus-maze: modulation by stressful handling. Behav Brain Res 220:344-8
48. Rohde P (2001) The relevance of hierarchies, territories, defeat for depression in humans: hypotheses and clinical predictions. J Affect Disord 65:221-30 (Pubitemid 32757153)
49. Rossi S, De Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G, Usiello A, Centonze D (2008) Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci 28:7284-92
50. Rumyantseva GM, Stepanov AL (2008) Post-traumatic stress disorder in different types of stress (clinical features and treatment). Neurosci Behav Physiol 38:55-61
51. Rygula R, Abumaria N, Flügge G, Hiemke C, Fuchs E, Rüther E, Havemann-Reinecke U (2006a) Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats. Behav Pharmacol 17:19-29 (Pubitemid 43068381)
52. Rygula R, Abumaria N, Domenici E, Hiemke C, Fuchs E (2006b) Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats. Behav Brain Res 174:188-92 (Pubitemid 44397187)
53. Schoevers RA, Van HL, Koppelmans V, Kool S, Dekker JJ (2008) Managing the patient with co-morbid depression and an anxiety disorder. Drugs 68:1621-34
54. Seligman ME (1975) Helplessness: on depression, development, and death. W.H. Freeman, San Francisco
55. Slattery DA, Uschold N, Magoni M, Bär J, Popoli M, Neumann ID, Reber SO (2012) Behavioural consequences of two chronic psychosocial stress paradigms: anxiety without depression. Psychoneuroendocrinology 37:702-14
56. Svenningsson P, Bateup H, Qi H, Takamiya K, Huganir RL, Spedding M, Roth BL, McEwen BS, Greengard P (2008) Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. Genes Brain Behav 7:933-42
57. Tordera RM, Monge A, Del Río J, Lasheras B (2002) Antidepressantlike activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors. Eur J Pharmacol 442:63-71 (Pubitemid 34521848)
58. Tordera RM, Totterdell S, Wojcik SM, Brose N, Elizalde N, Lasheras B, Del Rio J (2007) Enhanced anxiety, depressive-like behavior and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur J Neurosci 25:281-90 (Pubitemid 46096241)
59. Tordera RM, Garcia-García AL, Elizalde N, Segura V, Aso E, Venzala E, Ramírez MJ, Del Rio J (2011) Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex. Eur Neuropsychopharmacol 21:23-32
60. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-25
61. Uezato A, Meador-Woodruff JH, McCullumsmith RE (2009) Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia. Bipolar Disord 11:711-25
62. Wagner KV, Wang XD, Liebl C, Scharf SH, Müller MB, Schmidt MV (2011) Pituitary glucocorticoid receptor deletion reduces vulnerability to chronic stress. Psychoneuroendocrinology 36:579-87
63. Wallace DL, Han MH, Graham DL, Green TA, Vialou V, Iñiguez SD, Cao JL, Kirk A, Chakravarty S, Kumar A, Krishnan V, Neve RL, Cooper DC, Bolaños CA, Barrot M, McClung CA, Nestler EJ (2009) CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits. Nat Neurosci 12:200-9
64. Wilkinson MB, Xiao G, Kumar A, LaPlant Q, Renthal W, Sikder D, Kodadek TJ, Nestler EJ (2009) Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J Neurosci 29:7820-32
65. Willner P (1991) Animal models as simulations of depression. Trends Pharmacol Sci 12:131-6
66. Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioral-neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90-110 (Pubitemid 41160326)
67. Wojcik SM, Rhee JS, Herzog E, Sigler A, Jahn R, Takamori S, Brose N, Rosenmund C (2004) An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci USA 101:7158-63 (Pubitemid 38596459)
68. Yan HC, Qu HD, Sun LR, Li SJ, Cao X, Fang YY, Jie W, Bean JC, Wu WK, Zhu XH, Gao TM (2010) Fuzi polysaccharide-1 produces antidepressant-like effects in mice. Int J Neuropsychopharmacol 13:623-33